|
G
|
Abcc9
|
ATP binding cassette subfamily C member 9
|
multiple interactions
|
ISO
|
Creatine metabolite inhibits the reaction [Adenosine Monophosphate inhibits the reaction [Adenosine Triphosphate results in decreased activity of [KCNJ11 protein binds to ABCC9 protein]]]
|
CTD |
PMID:11390963 |
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G
|
App
|
amyloid beta precursor protein
|
increases secretion
|
ISO
|
Creatine analog results in increased secretion of APP protein modified form
|
CTD |
PMID:22906069 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G
|
Bdnf
|
brain-derived neurotrophic factor
|
multiple interactions increases expression
|
ISO
|
Sirolimus inhibits the reaction [Creatine results in increased expression of BDNF protein]
|
CTD |
PMID:33022268 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
EXP
|
[Creatine co-treated with Ribose] results in decreased activity of CASP3 protein
|
CTD |
PMID:21220914 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Col2a1
|
collagen type II alpha 1 chain
|
multiple interactions
|
EXP
|
[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatine; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatine]; huang-lien-chieh-tu-tang inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatine]
|
CTD |
PMID:24709313 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G
|
Csf3
|
colony stimulating factor 3
|
multiple interactions
|
ISO
|
[CSF3 protein co-treated with Paclitaxel] results in decreased abundance of Creatine
|
CTD |
PMID:9018096 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G
|
Dek
|
DEK proto-oncogene
|
increases chemical synthesis
|
ISO
|
DEK protein results in increased chemical synthesis of Creatine
|
CTD |
PMID:28558019 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
|
|
G
|
Gatm
|
glycine amidinotransferase
|
increases chemical synthesis
|
ISO
|
GATM protein results in increased chemical synthesis of Creatine
|
CTD |
PMID:16820567 |
|
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
|
|
G
|
Kcnj11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
multiple interactions
|
ISO
|
Creatine metabolite inhibits the reaction [Adenosine Monophosphate inhibits the reaction [Adenosine Triphosphate results in decreased activity of [KCNJ11 protein binds to ABCC9 protein]]]
|
CTD |
PMID:11390963 |
|
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
|
|
G
|
Mtor
|
mechanistic target of rapamycin kinase
|
increases phosphorylation multiple interactions
|
ISO
|
Creatine results in increased phosphorylation of MTOR protein Sirolimus inhibits the reaction [Creatine results in increased phosphorylation of MTOR protein]
|
CTD |
PMID:33022268 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
increases expression
|
ISO
|
Creatine results in increased expression of PPARGC1A mRNA
|
CTD |
PMID:23056435 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G
|
Snca
|
synuclein alpha
|
multiple interactions
|
ISO
|
[coenzyme Q10 co-treated with Creatine] results in decreased expression of SNCA protein
|
CTD |
PMID:19476553 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
|
G
|
Bmal1
|
basic helix-loop-helix ARNT like 1
|
increases abundance
|
ISO
|
BMAL1 gene mutant form results in increased abundance of Creatinine
|
CTD |
PMID:27056296 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G
|
Col2a1
|
collagen type II alpha 1 chain
|
multiple interactions
|
EXP
|
[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatinine; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatinine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatinine]; huang-lien-chieh-tu-tang inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatinine]
|
CTD |
PMID:24709313 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
multiple interactions increases abundance
|
ISO
|
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Creatinine]
|
CTD |
PMID:27469509 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G
|
Lepr
|
leptin receptor
|
affects abundance multiple interactions increases abundance
|
ISO
|
LEPR affects the abundance of Creatinine Glucagon analog inhibits the reaction [LEPR gene mutant form results in increased abundance of Creatinine]; swietenine inhibits the reaction [LEPR gene mutant form results in increased abundance of Creatinine]
|
CTD |
PMID:20567778 PMID:29988851 PMID:36066211 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased abundance of Creatinine
|
CTD |
PMID:28710020 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1
|
multiple interactions
|
EXP
|
[SC 560 results in decreased activity of PTGS1 protein] which results in increased abundance of Creatinine
|
CTD |
PMID:19629487 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G
|
Slc47a1
|
solute carrier family 47 member 1
|
multiple interactions
|
ISO
|
Creatinine inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:22419765 |
|
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
|
|
G
|
Slc47a2
|
solute carrier family 47 member 2
|
multiple interactions
|
ISO
|
Creatinine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:22419765 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G
|
Sod2
|
superoxide dismutase 2
|
decreases abundance
|
ISO
|
SOD2 protein results in decreased abundance of Creatinine
|
CTD |
PMID:19917352 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:37648050 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
EXP ISO
|
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of BAX protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of BAX protein] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]
|
CTD |
PMID:34358621 PMID:34455488 PMID:37597758 PMID:37648050 PMID:39043266 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bbc3
|
Bcl-2 binding component 3
|
multiple interactions decreases expression
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of BBC3 mRNA]; Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of BBC3 protein] Phosphocreatine results in decreased expression of BBC3 mRNA; Phosphocreatine results in decreased expression of BBC3 protein
|
CTD |
PMID:37597758 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions
|
EXP ISO
|
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]
|
CTD |
PMID:34455488 PMID:37648050 PMID:39043266 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
EXP ISO
|
7-oxozeanol inhibits the reaction [Phosphocreatine inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]]; Phosphocreatine inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of CASP3 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of CASP3 protein modified form]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of CASP3 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of CASP3 protein modified form] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein]
|
CTD |
PMID:34358621 PMID:34455488 PMID:37597758 PMID:37648050 PMID:39043266 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
EXP ISO
|
Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of CASP9 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of CASP9 protein] Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 protein]
|
CTD |
PMID:34455488 PMID:37648050 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Ccn2
|
cellular communication network factor 2
|
multiple interactions
|
EXP
|
Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTGF mRNA]
|
CTD |
PMID:37597758 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G
|
Ctnnd1
|
catenin delta 1
|
multiple interactions
|
EXP
|
Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTNND1 mRNA]
|
CTD |
PMID:37597758 |
|
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin affects the localization of CYCS protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of CYCS protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of CYCS protein]
|
CTD |
PMID:34455488 PMID:39043266 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G
|
Foxo3
|
forkhead box O3
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of FOXO3 protein]
|
CTD |
PMID:34358621 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of GSK3B protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased phosphorylation of GSK3B protein]
|
CTD |
PMID:34455488 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
multiple interactions
|
EXP
|
Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of IGF1R mRNA]
|
CTD |
PMID:37597758 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G
|
Ins1
|
insulin 1
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased secretion of INS1 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased secretion of INS1 protein]
|
CTD |
PMID:34455488 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G
|
Irs1
|
insulin receptor substrate 1
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of IRS1 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of IRS1 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased phosphorylation of IRS1 protein]
|
CTD |
PMID:34455488 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G
|
Lpl
|
lipoprotein lipase
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Dietary Fats results in decreased activity of LPL protein]
|
CTD |
PMID:37648050 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
multiple interactions
|
EXP
|
7-oxozeanol inhibits the reaction [Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of MAP3K7 protein]]; Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of MAP3K7 protein]; Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of MAP3K7 protein]
|
CTD |
PMID:34358621 |
|
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G
|
Mapk7
|
mitogen-activated protein kinase 7
|
decreases expression multiple interactions
|
EXP
|
Phosphocreatine results in decreased expression of MAPK7 mRNA Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of MAPK7 mRNA]
|
CTD |
PMID:37597758 |
|
NCBI chr10:46,170,264...46,176,262
Ensembl chr10:46,170,167...46,176,267
|
|
G
|
Mapt
|
microtubule-associated protein tau
|
decreases abundance multiple interactions
|
ISO
|
MAPT protein mutant form results in decreased abundance of Phosphocreatine PF-06840003 inhibits the reaction [MAPT protein mutant form results in decreased abundance of Phosphocreatine]
|
CTD |
PMID:39172838 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
|
|
G
|
Mir143
|
microRNA 143
|
multiple interactions increases expression
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of MIR143 mRNA] Phosphocreatine results in increased expression of MIR143 mRNA
|
CTD |
PMID:37597758 |
|
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
EXP
|
Phosphocreatine affects the reaction [Doxorubicin affects the expression of NFE2L2 protein]; Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]
|
CTD |
PMID:34358621 PMID:37597758 PMID:39043266 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
decreases expression multiple interactions
|
EXP
|
Phosphocreatine results in decreased expression of PDGFRA mRNA Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of PDGFRA mRNA]
|
CTD |
PMID:37597758 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of PPARGC1A protein]
|
CTD |
PMID:39043266 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G
|
Ppid
|
peptidylprolyl isomerase D
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPID protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased expression of PPID protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased expression of PPID protein]
|
CTD |
PMID:34455488 |
|
NCBI chr 2:164,727,803...164,740,168
Ensembl chr 2:164,727,779...164,740,221
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions decreases expression
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of PTGS2 mRNA] Phosphocreatine results in decreased expression of PTGS2 mRNA
|
CTD |
PMID:37597758 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G
|
Ripk3
|
receptor-interacting serine-threonine kinase 3
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of RIPK3 protein]
|
CTD |
PMID:34358621 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein]
|
CTD |
PMID:37597758 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G
|
Sod3
|
superoxide dismutase 3
|
multiple interactions
|
EXP
|
Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of SOD3 protein]
|
CTD |
PMID:34358621 |
|
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
increases response to substance multiple interactions
|
EXP
|
STAT3 protein results in increased susceptibility to Phosphocreatine Phosphocreatine inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of STAT3 protein]; Phosphocreatine inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of STAT3 protein]; Phosphocreatine inhibits the reaction [Streptozocin results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:34455488 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|